Venkateswaran Vidhya, Petter Ella, Boulier Kristin, Ding Yi, Bhattacharya Arjun, Pasaniuc Bogdan
Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Department of Oral Biology, School of Dentistry, University of California, Los Angeles, Los Angeles, CA 90095, USA.
medRxiv. 2023 Oct 3:2023.09.29.23296364. doi: 10.1101/2023.09.29.23296364.
Bilirubin is a potent antioxidant with a protective role in many diseases. We examined the relationships between serum bilirubin (SB) levels, tobacco smoking (a known cause of low SB), and aerodigestive cancers, grouped as lung (LC) and head and neck (HNC).
We examined the associations between SB, LC and HNC using data from 393,210 participants from UCLA Health, employing regression models, propensity score matching, and polygenic scores.
Current tobacco smokers showed lower SB (-0.04mg/dL, 95% CI: [-0.04, -0.03]), compared to never-smokers. Lower SB levels were observed in HNC and LC cases (-0.10 mg/dL, [-0.13, -0.09] and -0.09 mg/dL, CI [-0.1, -0.07] respectively) compared to cancer-free controls with the effect persisting after adjusting for smoking. SB levels were inversely associated with HNC and LC risk (ORs per SD change in SB: 0.64, CI [0.59,0.69] and 0.57, CI [0.43,0.75], respectively). Lastly, a polygenic score (PGS) for SB was associated with LC (OR per SD change of SB-PGS: 0.71, CI [0.67, 0.76]).
Low SB levels are associated with an increased risk of both HNC and LC, independent of the effect of tobacco smoking with tobacco smoking demonstrating a strong interaction with SB on LC risk. Additionally, genetically predicted low SB (from polygenic scores) is negatively associated with LC.
These findings suggest that SB could serve as a potential early biomarker for LC and HNC.
胆红素是一种强效抗氧化剂,在许多疾病中具有保护作用。我们研究了血清胆红素(SB)水平、吸烟(已知的低SB原因)与气消化道癌症之间的关系,气消化道癌症分为肺癌(LC)和头颈癌(HNC)。
我们使用来自加州大学洛杉矶分校健康中心的393210名参与者的数据,采用回归模型、倾向得分匹配和多基因评分,研究了SB、LC和HNC之间的关联。
与从不吸烟者相比,当前吸烟者的SB水平较低(-0.04mg/dL,95%CI:[-0.04,-0.03])。与无癌对照相比,HNC和LC病例的SB水平较低(分别为-0.10mg/dL,[-0.13,-0.09]和-0.09mg/dL,CI[-0.1,-0.07]),在调整吸烟因素后,这种效应仍然存在。SB水平与HNC和LC风险呈负相关(SB每标准差变化的OR值:分别为0.64,CI[0.59,0.69]和0.57,CI[0.43,0.75])。最后,SB的多基因评分(PGS)与LC相关(SB-PGS每标准差变化的OR值:0.71,CI[0.67,0.76])。
低SB水平与HNC和LC风险增加相关,独立于吸烟的影响,吸烟与SB对LC风险有强烈的相互作用。此外,基因预测的低SB(来自多基因评分)与LC呈负相关。
这些发现表明,SB可能是LC和HNC的潜在早期生物标志物。